If you hate taking pills, you might be excited by the invention of a coil that sits in the stomach slowly releasing medication over weeks.
This could play a major role in reducing deadly tuberculosis infections and the rapidly growing problem of antimicrobial resistance, says the device’s developer Malvika Verma of the Massachusetts Institute of Technology.
Once fully coiled, the device is 10 centimetres long and threaded with pills. “You have a hole in the pill, kind of like a candy necklace, and each pill can be a different drug,” says Verma.
The coil can be unfurled to deliver it to the stomach via the nose and throat, where it springs back into a coil again. This coil is too large to leave the stomach, so it stays there, and the medicines threaded onto it leach out at a rate depending on the type of drug and the polymer the developers use to make the pills.
After the drugs have dissolved away, the device can be retrieved via the nose and throat using a magnet attached to the coil.
Verma and her team decided to test how well the device would work delivering antibiotics to pigs. Over the course of a month, blood tests revealed the coil was steadily dispensing the medication into the body, and pigs suffered no apparent side effects such as weight loss, issues passing food or liquids or stomach injury.
They chose to trial the device with the kind of antibiotics used to treat TB because the condition requires people to take multiple tablets every day. For many patients, particularly those in remote areas, sticking to such a regime can be quite difficult.
Yet failing to do so contributes to the evolution of drug-resistant TB strains, and these are expected to account for one in four drug-resistant related deaths by 2050.
Verma and her team are hoping to perform the first human trial of the system within the next five years.
The device wouldn’t only be useful for conditions that need many pills per day to successfully treat. It could also help patients who are forgetful, or have conditions that interfere with reliable self-management, such as dementia or schizophrenia.
Journal reference: Science Translational Medicine, DOI: 10.1126/scitranslmed.aau6267
Quick Take: Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all-cause mortality
Urinary tract infection (UTI) is the most common bacterial infection in elderly patients, and the spectrum of illness ranges from...
Quick Take: Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines
Antibiotic resistance is a growing challenge across the globe. As such, there have been increasing efforts towards reducing unnecessary or...
Quick Take: Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics
Systemic antibiotics are commonly used in the treatment of acne. However, the impact of their use on the complete bacterial...
New herpes zoster vaccine predicted to be more cost effective than predecessor
1. In a computational model, the new “recombinant zoster vaccine” (RZV) was predicted to be most cost-effective than the previous...
@CDavidson1127 @HHSGov @CNN @cnnhealth @elizcohencnn If you’ve have been fully vaccinated with MMR or had measles infection, you’re considered protected for life from measles. You are also considered protected if you were born before 1957, have lab evidence of immunity, or lab confirmation of measles infection.